UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 452

Sortiert nach

Evidence for the involvement of the kainate receptor subunit GluR6 (GRIK2) in mediating behavioral displays related to behavioral symptoms of mania

Molecular psychiatry, 2008-09, Vol.13 (9), p.858-872

2008

Volltextzugriff (PDF)

Environmental enrichment requires adult neurogenesis to facilitate the recovery from psychosocial stress

Molecular psychiatry, 2010-12, Vol.15 (12), p.1152-1163

2010

Volltextzugriff (PDF)

Protein Kinase C Overactivity Impairs Prefrontal Cortical Regulation of Working Memory

Science (American Association for the Advancement of Science), 2004-10, Vol.306 (5697), p.882-884

2004

Volltextzugriff (PDF)

The extracellular signal-regulated kinase pathway contributes to the control of behavioral excitement

Molecular psychiatry, 2009-04, Vol.14 (4), p.448-461

2009

Volltextzugriff (PDF)

Translational research in bipolar disorder: emerging insights from genetically based models

Molecular psychiatry, 2010-09, Vol.15 (9), p.883-895

2010

Volltextzugriff (PDF)

Emerging experimental therapeutics for bipolar disorder: insights from the molecular and cellular actions of current mood stabilizers

Molecular psychiatry, 2004-08, Vol.9 (8), p.734-755

2004

Volltextzugriff (PDF)

Rapid antidepressant effects: moving right along

Molecular psychiatry, 2013-08, Vol.18 (8), p.856-863

2013

Volltextzugriff (PDF)

Neurotrophic signaling cascades in the pathophysiology and treatment of bipolar disorder

Current opinion in pharmacology, 2007-02, Vol.7 (1), p.22-26

2007

Volltextzugriff (PDF)

Increased anxiety-like behaviors and mitochondrial dysfunction in mice with targeted mutation of the Bcl-2 gene: Further support for the involvement of mitochondrial function in anxiety disorders

Behavioural brain research, 2005-12, Vol.165 (2), p.172-180

2005

Volltextzugriff (PDF)

Targeting the BH3-interacting domain death agonist to develop mechanistically unique antidepressants

Molecular psychiatry, 2012-08, Vol.17 (8), p.770-780

2012

Volltextzugriff (PDF)

Neuroplasticity and cellular resilience in mood disorders

Molecular psychiatry, 2000-11, Vol.5 (6), p.578-593

2000

Volltextzugriff (PDF)

Lithium at 50: have the neuroprotective effects of this unique cation been overlooked?

Biological Psychiatry, 1999-10, Vol.46 (7), p.929-940

1999

Volltextzugriff (PDF)

S.4.01 Molecular drug targets for bipolar disorders

European neuropsychopharmacology, 2010, Vol.20, p.S87-S89

Manji, H

2010

Volltextzugriff (PDF)

The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3

Journal of neurochemistry, 1999-03, Vol.72 (3), p.1327-1330

1999

Volltextzugriff (PDF)

Metabonomic analysis identifies molecular changes associated with the pathophysiology and drug treatment of bipolar disorder

Molecular psychiatry, 2009-03, Vol.14 (3), p.269-279

2009

Volltextzugriff (PDF)

Lithium increases N-acetyl-aspartate in the human brain: in vivo evidence in support of bcl-2’s neurotrophic effects?

Biological psychiatry (1969), 2000-07, Vol.48 (1), p.1-8

2000

Volltextzugriff (PDF)

The cellular neurobiology of depression

Nature medicine, 2001-05, Vol.7 (5), p.541-547

2001

Volltextzugriff (PDF)

The Role of the Extracellular Signal-Regulated Kinase Signaling Pathway in Mood Modulation

The Journal of neuroscience, 2003-08, Vol.23 (19), p.7311-7316

2003

Volltextzugriff (PDF)

Corrigendum to Routine blood monitoring in maintenance Immunoglobulin treatment of inflammatory neuropathy: Is it clinically relevant? [Journal of the Neurological Sciences 408 (2020) 116527]

Journal of the neurological sciences, 2020-10, Vol.417, p.116988-116988, Article 116988

2020

Volltextzugriff (PDF)

PKC, MAP kinases and the bcl-2 family of proteins as long-term targets for mood stabilizers

Molecular psychiatry, 2002-01, Vol.7 Suppl 1 (S1), p.S46-S56

2002

Volltextzugriff (PDF)

Routine blood monitoring in maintenance immunoglobulin treatment of inflammatory neuropathy: Is it clinically relevant?

Journal of the neurological sciences, 2020-01, Vol.408, p.116527-116527, Article 116527

2020

Volltextzugriff (PDF)

Neurology in Africa

Journal of the neurological sciences, 2017-10, Vol.381, p.151-151

Manji, H.

2017

Volltextzugriff (PDF)

Lithium up-regulates the cytoprotective protein Bcl-2 in the CNS in vivo: a role for neurotrophic and neuroprotective effects in manic depressive illness

The journal of clinical psychiatry, 2000, Vol.61 Suppl 9, p.82

2000

Volltextzugriff (PDF)

Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for Difficult-to-Treat depression

Biological Psychiatry, 2003-04, Vol.53 (8), p.707-742

2003

Volltextzugriff (PDF)

The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS

Journal of neurochemistry, 1999-02, Vol.72 (2), p.879-882

1999

Volltextzugriff (PDF)

1 – 25 von 452

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(402)
Mit Volltextzugriff
(378)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(452)
Japanisch
(68)

Erscheinungsjahr

n.n

Thema

Science & Technology
(307)
Life Sciences & Biomedicine
(286)
Humans
(258)
Biological And Medical Sciences
(143)
Medical Sciences
(140)
Male
(131)
Neurosciences & Neurology
(128)
Psychiatry
(126)
Neurosciences
(108)
Female
(105)
Animals
(98)
Adult
(89)
Psychology. Psychoanalysis. Psychiatry
(81)
Pharmacology. Drug Treatments
(62)
Middle Aged
(58)
Neuropharmacology
(54)
Clinical Neurology
(51)
Lithium
(51)
Psychopharmacology
(49)
Bipolar Disorder
(45)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Evidence for the involvement of the kainate receptor subunit GluR6 (GRIK2) in mediating behavioral displays related to behavioral symptoms of mania

Environmental enrichment requires adult neurogenesis to facilitate the recovery from psychosocial stress

Protein Kinase C Overactivity Impairs Prefrontal Cortical Regulation of Working Memory

The extracellular signal-regulated kinase pathway contributes to the control of behavioral excitement

Translational research in bipolar disorder: emerging insights from genetically based models

Emerging experimental therapeutics for bipolar disorder: insights from the molecular and cellular actions of current mood stabilizers

Rapid antidepressant effects: moving right along

Neurotrophic signaling cascades in the pathophysiology and treatment of bipolar disorder

Increased anxiety-like behaviors and mitochondrial dysfunction in mice with targeted mutation of the Bcl-2 gene: Further support for the involvement of mitochondrial function in anxiety disorders

Targeting the BH3-interacting domain death agonist to develop mechanistically unique antidepressants

Neuroplasticity and cellular resilience in mood disorders

Lithium at 50: have the neuroprotective effects of this unique cation been overlooked?

S.4.01 Molecular drug targets for bipolar disorders

The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3

Metabonomic analysis identifies molecular changes associated with the pathophysiology and drug treatment of bipolar disorder

Lithium increases N-acetyl-aspartate in the human brain: in vivo evidence in support of bcl-2’s neurotrophic effects?

The cellular neurobiology of depression

The Role of the Extracellular Signal-Regulated Kinase Signaling Pathway in Mood Modulation

Corrigendum to Routine blood monitoring in maintenance Immunoglobulin treatment of inflammatory neuropathy: Is it clinically relevant? [Journal of the Neurological Sciences 408 (2020) 116527]

PKC, MAP kinases and the bcl-2 family of proteins as long-term targets for mood stabilizers

Routine blood monitoring in maintenance immunoglobulin treatment of inflammatory neuropathy: Is it clinically relevant?

Neurology in Africa

Lithium up-regulates the cytoprotective protein Bcl-2 in the CNS in vivo: a role for neurotrophic and neuroprotective effects in manic depressive illness

Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for Difficult-to-Treat depression

The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS

Suchergebnisse filtern